Defunct Company
Total Trials
16
As Lead Sponsor
7
As Collaborator
9
Total Enrollment
490
NCT00113724
Study of TPI 287 in Patients With Advanced Malignancies
Phase: Phase 1
Role: Lead Sponsor
Start: May 31, 2005
Completion: Jan 31, 2008
NCT00256191
Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies
Start: Nov 30, 2005
Completion: Feb 28, 2007
NCT00479635
A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer
Phase: Phase 2
Start: Jan 31, 2007
Completion: Aug 31, 2008
NCT00553813
A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer
Start: Oct 31, 2007
Completion: Apr 30, 2010
NCT00867568
TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma
Role: Collaborator
Start: Mar 31, 2009
Completion: Feb 29, 2016
NCT01067066
A Phase I Study of TPI 287 - Temozolomide Combination in Melanoma
Start: Feb 3, 2010
Completion: Jul 6, 2016
NCT01113463
TPI 287 in Patients With Recurrent Glioblastoma Multiforme
Start: Apr 30, 2010
Completion: Dec 31, 2012
NCT01332630
TPI 287 in Breast Cancer Metastatic to the Brain
Start: Aug 16, 2011
Completion: Apr 14, 2017
NCT01483820
Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma
Phase: Phase 1/2
Start: Dec 31, 2011
Completion: Dec 31, 2014
NCT01505608
Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma
NCT01582152
Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma
Start: Jul 31, 2012
Completion: Mar 31, 2016
NCT01933815
Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
Start: Aug 31, 2013
Completion: May 31, 2025
NCT01340729
Open-Label Study of TPI 287 for Patients With Metastatic Melanoma
Start: Sep 30, 2013
Completion: Not specified
NCT02047214
Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy
Start: Jan 31, 2014
Completion: Dec 31, 2015
NCT02187822
Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases
Start: Oct 9, 2014
Completion: Mar 31, 2018
NCT06333782
Evaluation of the Safety and Efficacy of Hyaluronic Acid Injection in Labia Majora Augmentation
Phase: N/A
Start: May 22, 2024
Completion: Jul 1, 2025